VMP 42130011000001101

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Gabapentin 800mg tablets
BNF code 0408010G0AAAKAK
Virtual Therapeutic Moiety Gabapentin
Date identifier became valid 4 Aug 2023
Previous product identifier 323022001
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Gabapentin
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 800.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category Schedule 3 (CD No Register Exempt Safe Custody)
Date of applicability 1 Apr 2019
Previous Controlled Drug information No Controlled Drug Status
Actual Medicinal Products
Gabapentin 800mg tablets (A A H Pharmaceuticals Ltd)
Gabapentin 800mg tablets (Accord-UK Ltd)
Gabapentin 800mg tablets (Alliance Healthcare (Distribution) Ltd)
Gabapentin 800mg tablets (Brown & Burk UK Ltd)
Gabapentin 800mg tablets (Glenmark Pharmaceuticals Europe Ltd)
Gabapentin 800mg tablets (Medihealth (Northern) Ltd)
Gabapentin 800mg tablets (Milpharm Ltd)
Gabapentin 800mg tablets (Morningside Healthcare Ltd)
Gabapentin 800mg tablets (Sigma Pharmaceuticals Plc)
Gabapentin 800mg tablets (Strides Pharma UK Ltd)
Neurontin 800mg tablets (Viatris UK Healthcare Ltd)
Virtual Medicinal Product Packs
Gabapentin 800mg tablets 100 tablet

dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.

Feedback